Evidence map›Paper›PMID 23212446›Full record

ArticleMolecular and cellular biochemistry2013

Treatment with hydrogen molecule alleviates TNFα-induced cell injury in osteoblast.

Wen-Wen Cai, Ming-Hua Zhang, Yong-Sheng Yu, Jin-Hua Cai

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Molecular hydrogen is a promising therapeutic agent for pulmonary disease.Journal of Zhejiang University. Science. B · 2022
    Article
  10. Article
  11. Review
  12. Recent Advances in Studies of Molecular Hydrogen against Sepsis.International journal of biological sciences · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. NADPH oxidases in bone homeostasis and osteoporosis.Cellular and molecular life sciences : CMLS · 2015
    Review
  18. Article
  19. Three hydrogen-rich solutions protect against intestinal injury in uncontrolled hemorrhagic shock.International journal of clinical and experimental medicine · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Wen-Wen CaiThe Centre of Drug Safeguard, Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
Ming-Hua Zhang
Yong-Sheng Yu
Jin-Hua Cai
Chinese People's Liberation Army · CNPeople's Liberation Army No. 150 Hospital · CNSecond Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor necrosis factor-alpha (TNFα) plays a crucial role in inflammatory diseases such as rheumatoid arthritis and postmenopausal osteoporosis. Recently, it has been demonstrated that hydrogen gas, known as a novel antioxidant, can exert therapeutic anti-inflammatory effect in many diseases. In this study, we investigated the effect of treatment with hydrogen molecule (H(2)) on TNFα-induced cell injury in osteoblast. The osteoblasts isolated from neonatal rat calvariae were cultured. It was found that TNFα suppressed cell viability, induced cell apoptosis, suppressed Runx2 mRNA expression, and inhibited alkaline phosphatase activity, which was reversed by co-incubation with H(2). Incubation with TNFα-enhanced intracellular reactive oxygen species (ROS) formation and malondialdehyde production increased NADPH oxidase activity, impaired mitochondrial function marked by increased mitochondrial ROS formation and decreased mitochondrial membrane potential and ATP synthesis, and suppressed activities of antioxidant enzymes including SOD and catalase, which were restored by co-incubation with H(2). Treatment with H(2) inhibited TNFα-induced activation of NFκB pathway. In addition, treatment with H(2) inhibited TNFα-induced nitric oxide (NO) formation through inhibiting iNOS activity. Treatment with H(2) inhibited TNFα-induced IL-6 and ICAM-1 mRNA expression. In conclusion, treatment with H(2) alleviates TNFα-induced cell injury in osteoblast through abating oxidative stress, preserving mitochondrial function, suppressing inflammation, and enhancing NO bioavailability.

Indexed as

Alkaline PhosphataseAnimalsAnti-Inflammatory AgentsAntioxidantsApoptosisCells, CulturedCell SurvivalCore Binding Factor Alpha 1 SubunitGene SilencingHydrogenIntercellular Adhesion Molecule-1Interleukin-6Membrane Potential, MitochondrialMitochondriaNF-kappa BNitric OxideAlkaline PhosphataseAnti-Inflammatory AgentsAntioxidantsCore Binding Factor Alpha 1 SubunitHydrogenIntercellular Adhesion Molecule-1Interleukin-6NF-kappa BNitric OxideNitric Oxide Synthase Type IINos2 protein, ratReactive Oxygen SpeciesRunx2 protein, ratTumor Necrosis Factor-alpha

Identifiers

PMID23212446
OpenAlexW2021965903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.